首页> 外文期刊>Free radical research >Attenuation of the acute adriamycin-induced cardiac and hepatic oxidative toxicity by N-(2-mercaptopropionyl) glycine in rats.
【24h】

Attenuation of the acute adriamycin-induced cardiac and hepatic oxidative toxicity by N-(2-mercaptopropionyl) glycine in rats.

机译:N-(2-巯基丙酰基)甘氨酸对大鼠急性阿霉素诱导的心脏和肝脏氧化毒性的减弱。

获取原文
获取原文并翻译 | 示例
       

摘要

The protective effect of the synthetic aminothiol, N-(2-mercaptopropionyl) glycine (MPG) on adriamycin (ADR) induced acute cardiac and hepatic oxidative toxicity was evaluated in rats. ADR toxicity, induced by a single intraperitoneal injection (15 mg/kg), was indicated by an elevation in the level of serum glutamic pyruvic transaminase (GPT), glutamic oxaloacetic transaminase (GOT), creatine kinase isoenzyme (CK-MB), and lactic dehydrogenase (LDH). ADR produced significant elevation in thiobarbituric acid reactive substances (TBARS), indicating lipid peroxidation, and significantly inhibited the activity of superoxide dismutase (SOD) in heart and liver tissues. In contrast, a single injection of ADR did not affect the cardiac or hepatic glutathione (GSH) content and cardiac catalase (CAT) activity but elevated hepatic CAT. Pretreatment with MPG, (2.5 mg/kg) intragastrically, significantly reduced TBARS concentration in both heart and liver and ameliorated the inhibition of cardiac and hepatic SOD activity. In addition, MPG significantly decreased the serum level of GOT, GPT, CK-MB, and LDH of ADR treated rats. These results suggest that MPG exhibited antioxidative potentials that may protect heart and liver against ADR-induced acute oxidative toxicity. This protective effect might be mediated, at least in part, by the high redox potential of sulfhydryl groups that limit the activity of free radicals generated by ADR.
机译:在大鼠中评估了合成的氨基硫醇N-(2-巯基丙酰基)甘氨酸(MPG)对阿霉素(ADR)诱导的急性心脏和肝脏氧化毒性的保护作用。一次腹膜内注射(15 mg / kg)引起的ADR毒性通过血清谷氨酸丙酮酸转氨酶(GPT),谷草草酰乙酸转氨酶(GOT),肌酸激酶同工酶(CK-MB)和乳酸脱氢酶(LDH)。 ADR使硫代巴比妥酸反应性物质(TBARS)显着升高,表明脂质过氧化,并显着抑制心脏和肝脏组织中超氧化物歧化酶(SOD)的活性。相比之下,单次注射ADR不会影响心脏或肝脏的谷胱甘肽(GSH)含量和心脏过氧化氢酶(CAT)活性,但会增加肝脏CAT。胃内MPG(2.5 mg / kg)预处理可显着降低心脏和肝脏中的TBARS浓度,并改善对心脏和肝脏SOD活性的抑制作用。此外,MPG显着降低了ADR治疗大鼠的GOT,GPT,CK-MB和LDH的血清水平。这些结果表明,MPG具有抗氧化潜力,可以保护心脏和肝脏免受ADR诱导的急性氧化毒性。这种保护作用可能至少部分地受到巯基基团的高氧化还原电势的限制,后者限制了ADR产生的自由基的活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号